1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer
Paulsson, J. ; Rydén, Lisa LU
; Strell, C
; Frings, O
; Tobin, Nicholas P
LU
; Fornander, T.
; Bergh, J.
; Landberg, Göran
LU
; Ståhl, O.
and Östman, A.
(2017)
In The Journal of Pathology: Clinical Research
3(1).
p.38-43
Mark
- 2010
-
STROMA-DERIVED MARKERS PREDICTING BREAST CANCER PROGNOSIS AND TREATMENT RESPONSE
Ostman, A. ; Paulsson, J. ; Liu, T. ; Rydén, Lisa LU
; Jirström, Karin
LU
; Landberg, Göran
LU
and Bergh, J.
(2010)
IMPAKT Breast Cancer Conference 2010
In Annals of Oncology
21.
p.115-115
Mark
- 2009
-
Vascular endothelial growth factor receptor 2 is a significant negative prognostic biomarker in triple-negative breast cancer: results from a controlled randomised trial of premenopausal breast cancer
Rydén, Lisa LU
; Fernö, Mårten
LU
; Stal, O
; Linderholm, B.
; Ostman, A
and Jirström, Karin
LU
(2009)
31st Annual San Antonio Breast Cancer Symposium
In Cancer Research
69(2).
p.132-132
Mark
- IDENTIFICATION OF NOVEL SECRETED TUMOR STROMA-DERIVED STIMULATORS OF PROSTATE CANCER GROWTH
- 2000
- PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor.
- 1991
-
Aspartic proteinase from barley seeds is related to animal cathepsin D
Tormakangas, K. ; Runeberg-Roos, P. ; Ostman, A. ; Tilgmann, C. LU
; Sarkkinen, P.
; Kervinen, J.
; Mikola, L.
and Kalkkinen, N.
(1991)
In Advances in Experimental Medicine and Biology
306.
p.355-359
Mark